IGF2BP3 and urinary bladder carcinoma: Analysis from GSE19423, a Bacillus Calmette–Guérin (BCG) immunotherapy of bladder cancer dataset, also revealed that a high level of IGF2BP3 was associated with favorable overall survival and cancer-specific survival in patients with bladder cancer (Fig. 7R).